Great Point Partners LLC Fibrogen Inc Call Options Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$10.18 - $26.64 $5.09 Million - $13.3 Million
-500,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.57 - $35.68 $9.29 Million - $17.8 Million
500,000 New
500,000 $13.3 Million
Q1 2021

May 17, 2021
SELL
$31.0 - $55.72 $5.16 Million - $9.28 Million
-166,500 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$37.09 - $48.97 $6.18 Million - $8.15 Million
166,500 New
166,500 $6.18 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $46.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email